253 assets in Diffuse Large B-Cell Lymphoma

Abbv-319

Abbv-525

Adi-001

Anti-Cd19-Car Cmv-Specific T-Lymphocytes

Anti-Pd1 Armored Cd19 Car-T Cells

CD19-7x19 CAR-T

cd19 car-t expressing il7 and ccl19

cd30.car-t

cd79b-19 car t cells

Clic-2201

cy-219 car-t

Ebv Tcr-T

ezm0414

Icovamenib

iks03

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer

Jwcar201

Loncastuximab

lp-168

lv20.19 car t cells

Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine

Onm-501

pf-08046032

Roflumilast

Stk-009

Surovatamig

Syncar-001

Taa-Specific Ctls

zm008

Anti-Cd19/Cd22 Car-T Cells

ct1182

ft596

Allogeneic Natural Killer Cells

Atg-010

18f-fluorapotrace

Anti-Cd19 Car Nk Cells

Anti Cd30 Car-T Cell

Metabolically Armed Cd19 Car-T Cells

rd14-01 cell

Human Interleukin 2 (Il2, T-Cell Growth Factor, Tcgf) (2-133) Variant (A1 Deleted, Pro65>Lys, Cys125>Ser), Non-Glycosylated, Produced In Escherichia Coli, Conjugated At N6 Of K65 With A Peg Derivative (30Kda)

Autologous Anti-Cd19 Car-Expressing T Lymphocytes

ms-553

Mtm-H-001